Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Physalia-courses
    Member
    • May 2017
    • 89

    Genomic Data Visualization using R

    Dear all,

    we have the last places available on our Workshop "Genomic Data Visualization and Interpretation" which will be held in Berlin (8-12 April).



    Registration deadline: 6th March 2019




    Instructors:

    Dr Obi Griffith and Dr Malachi Griffith (Department of Medicine, Washington University School of Medicine, US)


    Course website: https://www.physalia-courses.org/cou...hops/course14/


    In this workshop we will explore a number of best-in-class visualization tools, and provide working examples that demonstrate important principles of ‘omic interpretation strategies.

    This workshop is aimed at researchers and technical workers who are analyzing some kind of omic data (e.g. WGS, exome, RNA-seq, variant files, etc.). Examples demonstrated in this Workshop will involve primarily human genome/transcriptome data but many of the concepts learned will be applicable to model organisms, metagenomics, simulated data, etc.


    For more information about the program, please visit our website: https://www.physalia-courses.org/cou...curriculum-14/



    Here is the full list of our courses and Workshops: https://www.physalia-courses.org/courses-workshops




    Should you have any questions, please feel free to contact us: [email protected]

    Best regards,

    Carlo









    --------------------

    Carlo Pecoraro, Ph.D


    Physalia-courses DIRECTOR

    [email protected]

    Physalia-courses provide hands-on scientific training courses and workshops in bioinformatics, genomics, and related fields, helping researchers stay at the forefront of emerging methods and cutting-edge techniques. Our mission is to create a dynamic knowledge-sharing platform, connecting highly qualified instructors with participants at all stages of their scientific careers—from PhD students and postdoctoral researchers to principal investigators—as well as professionals working in industry. We foster collaboration, skill development, and innovation by bringing together expertise from academia and industry and creating opportunities for meaningful exchange across disciplines and sectors. Physalia promotes a modular approach to learning, enabling students and working professionals to build flexible, personalised learning pathways. Through focused courses and specialised training, learners can develop practical skills that respond to the evolving needs of the job market, while combining different learning experiences to strengthen their professional profiles and advance their careers.


    Twitter: @physacourses

    mobile: +49 17645230846

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:41 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...